Savara Inc.
XNAS:SVRA
6.5
$6.57 - 1,300.00
$6.30 - 100.00
$6.31
$6.58
$6.4
$6.37
6.61
1.89
4016550
3837276.2
85963805.72
Chart
TendieTensor AI Analysis
Company
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Fundamentals
59
-12.150000
11.665400
100
BBG000MS0823
BBG001SFTVM9
172.84M
201.30M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own SVRA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.